Fluicell.
High-Precision Tissue Engineering | Sweden
Client
Duration
Year
Status
Disorganized data. Manual tracking. Critical bottlenecks.
Fluicell is a pioneering Swedish biotech company based in Gothenburg, specializing in high-precision tissue engineering and microfluidics. They develop innovative solutions for regenerative medicine and drug screening, requiring meticulous handling of complex single-cell analysis data. The company faced a critical inflection point: their reliance on shared storage servers and manual file management was impeding research efficiency. With no unified sample tracking or metadata relationships, researchers struggled to locate critical experimental data, leading to compliance risks and stalling collaboration. They needed a sophisticated database solution to turn scattered files into actionable scientific intelligence.
Modular Architecture, Complex Querying & Agile Development
We architected a robust, scalable full-stack solution utilizing NestJS and PostgreSQL to replace the legacy file system. We established a dynamic database schema capable of handling complex relationships between samples and entries, ensuring data integrity and retrievability from day one. We developed an intuitive NextJS frontend designed specifically for scientist workflows. To guarantee a best-in-class user experience, we engineered a seamless interface for their file management, bridging the gap between complex data structures and effortless file retrieval. We implemented advanced multi-parameter search capabilities, allowing researchers to query instantly by cell types, drug treatments, and date ranges, a functionality that was previously impossible. We delivered a modular system designed for longevity and expansion. By taking full ownership of the software lifecycle, we embedded comprehensive audit trails and user activity tracking, ensuring compliance while creating a foundation that can easily adapt to future tissue therapeutics requirements.
Centralized intelligence. 8-week delivery. Accelerated research.
We successfully deployed the comprehensive database solution within an aggressive 8-week timeline. The immediate impact was the elimination of data silos; researchers transitioned from manual folder hunting to a centralized, searchable digital asset management system without operational downtime. Data retrieval efficiency improved dramatically, shifting from hours of manual searching to instant query results. The new system now captures 100% of sample metadata and relationships, enabling complex cross-experiment analysis that directly supports efficient drug screening and regenerative medicine development. Fluicell now operates on a scalable, secure platform with full audit capabilities. The modular architecture ensures that as their research volume grows, the system grows with them, securing their position at the cutting edge of microfluidics technology.
A curated selection of projects that embody our vision for AI-driven innovation and future-ready digital ecosystems.
